Objective: The aim of this study is to identify people at high risk for Obstructive Sleep Apnea (OSA) and to evaluate the impact of OSA on the control of cardiovascular risk factors.
INTRODUCTION
Obstructive Sleep Apnea (OSA) is a breathing disorder in which the affected person frequently stops breathing during sleep as a result of obstruction of the upper airways due to inadequate motor tone of the tongue and/or airway dilator muscles 1 . It is diagnosed by using overnight standardized, facility-based polysomnography to detect the frequency of apnea and hypopnea events. OSA is diagnosed when the apnea and hypopnea index (the number of events per hour) is greater than 15 or greater than 5 in a person who reports any of the following: unintentional sleep episodes during wakefulness, daytime sleepiness, non-refreshing sleep, fatigue, insomnia, waking up breath holding, gasping, or choking, or the bed partner describing loud snoring, breathing interruptions or both during the patient's sleep 2 .
Obstructive sleep apnea is a common primary health care problem [3] [4] [5] [6] . Furthermore, OSA is associated with serious clinical conditions; it could worsen diabetes and blood pressure (BP) 7, 8 . In addition, OSA increases the risks for stroke, heart failure, neuropathy, depression, road traffic accidents, cancer and mortality [9] [10] [11] [12] [13] [14] .
The relationship between diabetes and OSA is bidirectional. Obstructive sleep apnea is a risk factor for diabetes independent of traditional risk factors 15, 16 . Furthermore, it has been found that the level of glycated hemoglobin increases linearly with the severity of OSA in non-diabetic individuals 17 . On the other hand, OSA is highly prevalent among people with diabetes 4, 5, [18] [19] [20] .
Screening for OSA is important for various reasons. While OSA is common, it remains largely undiagnosed 4, 5, [20] [21] [22] . Presentation of OSA could be atypical 23, 24 . Furthermore, OSA is commonly associated with known diabetic complications 4, [9] [10] [11] 25, 26 . Lastly, screening and initiation of treatment may contribute to prevention and improved control of co-morbid conditions 16, [27] [28] [29] .
There are no studies about OSA among people with diabetes in the Kingdom of Bahrain.
The aim of this study is to identify people at high risk for OSA and to evaluate the impact of OSA on the control of cardiovascular risk factors.
METHOD
Four health centers were chosen randomly. Patients who attended diabetes clinics between 15 April to 15 July 2013 were invited to participate in the study. Patients were screened by using the Berlin questionnaire. This questionnaire has been validated for OSA screening in primary care and other settings 3, 5, 6, 22, [30] [31] [32] [33] [34] . The questionnaire has been validated in patients with diabetes 5, 20 . The Arabic version of this questionnaire has recently been used in a similar study; the author has been contacted and permission was granted to use the Arabic version in our study 33 .
The questionnaire is a self-report instrument that is focused on a set of known symptoms and clinical features associated with sleep apnea. One introductory question and four follow-up questions concerned snoring, witnessed apneas and the frequency of such events. Three questions addressed daytime sleepiness with a sub-question about drowsy driving. One question asked about history of high BP. Body Mass Index (BMI) is calculated based on self-reported height and weight of the participant. However in this study, we obtained the most recent BMI of the surveyed patients from their medical records.
High risk and lower risk groups for OSA are based on responses. Category 1, a positive score for risk is defined as frequent symptoms (more than three to four times per week or almost every day) in the questions about snoring and witnessed apneas; category 2, a positive score for risk is frequent symptoms in two or more questions about awakening sleepy, wake time sleepiness, and/or drowsy driving; category 3, a positive score for risk is defined as a self-report of high BP and/or BMI of ≥30 kg/m 2 . To score high for OSA, an individual's questionnaire must have had positive scores in two of the three categories or in all three. Those patients who denied having symptoms with such frequency, or who qualified in only one category are classified as low risk group 30 .
In addition, we reviewed the patients' medical records for age, gender, BMI, BP, lipid profile, glycated hemoglobin (A1C), drugs used for hypertension and medications (oral and injectables) used to treat diabetes. We defined controlled BP, A1C, and lipid parameters according to recent American Diabetes Association (ADA) guidelines 36 .
Data were analyzed by using SPSS software, version 20. Chi-squared test was used to assess the association between OSA and each of the following factors: age, gender, BMI, level of control of BP, A1C, lipid profile, antihypertensive and hypoglycemic drugs used. Multiple logistic regression model that included all the studied risk factors and OSA status as the dependent variable was set to determine the independent predictors for OSA. P-value less than 0.05 was considered statistically significant.
RESULT
We surveyed 484 patients. Twenty-nine questionnaires were excluded because they were incomplete. A total of 455 questionnaires were analyzed. All patients were type 2. The mean age was 56.6 years. Two hundred sixty-six (58.5%) were females. High risk for OSA was present in 173 (38%) patients, see table 1. There was no significant gender difference between age groups (P value= 0.113). Risk for OSA was more common among females (113/173; 65%) and the association was statistically significant (P=0.013). There was no significant association between risk for OSA and age groups, see table 2. There was no significant difference in the number of anti-diabetic medications used between low and high OSA risk patients (P=0.825). Three (1.7%) patients out of 173 from high OSA risk and 2 (0.71%) out of 282 from low OSA risk had previous OSA diagnosis.
In the multiple logistic regressions model, BMI was found to be a significant predictor for OSA [P value<0.001, Odds ratio 0.674 (0.562-0.809)].
DISCUSSION
This study showed that over one-third of the patients are at high risk for OSA. It is more common among females. It is associated with moderate and severe obesity, but not with age, diabetes or lipid control. It was also found that OSA is mainly undiagnosed among the patients surveyed.
The prevalence of OSA (37.4%) found in this study is similar to a study using pulse oximetry; however, the prevalence in our study is likely to be underestimated because the prevalence of obesity in our study was 58% compared to 32% 37 . In a study using the Berlin questionnaire, the prevalence was 48%; most patients (96.8%) were either obese or hypertensive 5 . Obesity and hypertension are known risk factors for OSA which are prevalent among our study participants [18] [19] [20] 38, 39 . Indeed, obesity not only predicts OSA, but also its severity 40 . Furthermore, the presence of co-morbid obesity and hypertension among these patients increase the risk for OSA significantly 41 . In addition, females who constituted about 58% of our study's participants are more likely to present with atypical symptoms 23, 39, 42 .
In this study, OSA was common in females. Male gender is a known risk factor for OSA as found in several studies 6, 18, 32, 35, 39 . The likely explanation for our finding is that most female patients (75.2%) were either peri-menopausal or menopausal (≥50 years), most of the high risk patients (75.7%) were in this age group. Male predominance usually disappears in older age and the risk for OSA increases with menopause 39, [43] [44] [45] . In addition, about two-third of the obese patients in the study were females.
In this study, hypertension was present in about two-third of the patients, while 75% of the high risk group were hypertensive. Hypertension is strongly associated with OSA. It is an independent risk factor for OSA and patients with OSA are at higher risk to develop hypertension 46, 47 . OSA was found to be the most common cause of secondary resistant hypertension 48 . Hence, the presence of resistant hypertension should urge the treating physician to evaluate the patient for OSA.
The study showed that A1C is almost similar between low and high risk group while lipids control was worse in high risk group but did not reach statistical significance. However, the level of control is far from optimal level as found in a recent study 49 . While some studies found that treatment of OSA improves A1C, the results are inconsistent 7, 29, 50 .
The strong association between OSA and metabolic syndrome components on one hand and the presence of mixed results about the efficacy of OSA treatment (especially in mild to moderate cases) highlights the importance of screening 51 . Unfortunately, this study found that only 2 patients from high risk group had previous OSA diagnosis. However, under-diagnosis is a consistent finding in primary care settings 4, 5, 21, 22, 52 . This could be related to lack of awareness of the treating physicians about OSA and its consequences 53 .
CONCLUSION
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